The Dermatology Digest

FEBRUARY 27, 2024

Pelage Pharmaceuticals has closed a $16.75 We have uncovered a small molecule able to stimulate cellular metabolism to re-awaken hair follicle stem cells and spur new hair growth,” says William Lowry, PhD, scientific co-founder, Pelage Pharmaceuticals, in a news release.

Pharmaceutical 36

Pharmaceutical Treatments Hospital Clinic 36

Dermatology Times

JANUARY 26, 2024

ICYMI, this week we had news about the completion of LEO Pharma's acquisition of Timber Pharmaceuticals, research pointing to melanoma overdiagnosis in White patients, artificial intelligence in skin cancer detection, and more.

Pharmaceutical 78

Pharmaceutical 78

Dermatology Times

MAY 7, 2024

ASLAN Pharmaceuticals presented new data this morning, including a 90% EASI score reduction.

Pharmaceutical 74

Pharmaceutical 74

Renee Rouleau

JANUARY 19, 2024

Pharmaceutical and Medical Advancements Ingredients that have been traditionally used for non-skincare purposes are now finding their way into the beauty industry. For example, witch hazel , previously used in wound healing and as a vasoconstrictor in modern medicine, is now used for soothing the skin and reducing excess oil production.

Skincare 195

Skincare Innovations Ingredients Oily Skin 195

Dermatology Times

FEBRUARY 29, 2024

The collaboration with Sato marks a continued effort of Arcutis to collaborate with pharmaceutical companies and license topical roflumilast in Asia.

Pharmaceutical 73

Pharmaceutical 73

Dermatology Times

APRIL 27, 2024

Keep up with the latest headlines in dermatology from the past week, including the appointment of All Detergent's first chief dermatology advisor, Incyte's acquisition of Escient Pharmaceuticals, and more.

Pharmaceutical 74

Pharmaceutical Dermatology 74

Dermatology Times

AUGUST 14, 2024

Myron Czuczman, MD, of Citius Pharmaceuticals recently shared perspectives on the role and potential of Lymphir in CTCL.

Pharmaceutical 71

Pharmaceutical 71

Dermatology Times

JUNE 21, 2024

Botanix Pharmaceuticals announced the approval of its sofpironium topical gel, 12.45% for adults and children ages 9 and older.

Pharmaceutical 62

Pharmaceutical 62

Dermatology Times

AUGUST 26, 2023

Keep up with the latest headlines in dermatology from the past week, including growing concerns of a dermatologist shortage in Ontario, LEO Pharma's acquisition of Timber Pharmaceuticals, and more. This week, we have also included a patient-forward rundown of top headlines to share with your patients.

Pharmaceutical 69

Pharmaceutical Dermatology 69

Kim Gallo Esthetics

MAY 31, 2023

Also known as pharmaceutical-grade , medical-grade skincare is exactly what it sounds like - products that are both developed and tested by medical professionals. Keep reading to find out why medical-grade skincare works better and which brand of professional-grade product is right for you. What is medical-grade skincare?

Medical Grade Skincare 195

Medical Grade Skincare Medical Skincare Skincare Brands 195

The Dermatology Digest

JANUARY 29, 2024

Medicaid and Medicare patient populations,” says Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, in a news release. “In “By securing a permanent J-Code for YCANTH, we have successfully reached a critical milestone in our commercial strategy that we expect will help us accelerate YCANTH utilization among the U.S.

Pharmaceutical 74

Pharmaceutical Office Medical Management 74

The Dermatology Digest

SEPTEMBER 12, 2024

In 2011, Mr. Clark co-founded and served as President and CEO of Clark Pharmaceuticals, where he launched and sold several more over-the-counter dermatology products. His passing is a true loss to the dermatology world, as his contributions helped treat millions of people with skin diseases.

Dermatology 74

Dermatology Pharmaceutical Skincare 74

The Dermatology Digest

FEBRUARY 8, 2024

Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Food and Drug Administration (FDA) recently OKed a label update for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Immunotherapy including cemiplimab (Libtayo, Regeneron Pharmaceuticals) has also brought hope to even the most difficult tumors,” he says.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

Dermatology Times

OCTOBER 3, 2024

This expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions

Pharmaceutical 45

Pharmaceutical 45

The Dermatology Digest

MAY 15, 2024

Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. FDA and Japan’s Pharmaceuticals and Medical Device Agency (PMDA) on the proposed design of the Phase 3 clinical trial. With a prevalence of approximately 22 million patients in the U.S.

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

Dermatology Times

DECEMBER 19, 2023

Dr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options.

Pharmaceutical 36

Pharmaceutical Dermatitis Therapy 36

The Dermatology Digest

AUGUST 21, 2024

Food and Drug Administration, according to Leo Pharma and Timber Pharmaceuticals. LEO Pharma acquired TMB-001 from Timber Pharmaceuticals in January 2024 following Timber’s Chapter 11 bankruptcy filing. As a consequence of the acquisition, Timber Pharmaceuticals was reformed as a fully owned subsidiary of LEO Pharma.

Pharmaceutical 36

Pharmaceutical Clinic Office Safety 36

The Dermatology Digest

FEBRUARY 5, 2024

Food and Drug Administration has expanded the indication for dupilumab (Dupixent, Sanofi, Regeneron Pharmaceuticals, Inc.) Management in the form of diet, drugs, and/or esophageal dilation — known as the “3 Ds” — is recommended to prevent long-term complications.

Eczema 74

Eczema Pharmaceutical Management Diet 74

Spa Executive

NOVEMBER 18, 2024

.” Li, director of Waterloo’s Printable Electronic Materials Lab, said in a statement: “AI technology is evolving rapidly, offering sophisticated signal analysis for health monitoring, food and pharmaceutical storage, environmental monitoring, and more.

Technology 52

Technology Pharmaceutical Innovations Marketing 52

The Dermatology Digest

JANUARY 2, 2024

featured the pharmaceutical industry. In all, 28.7% featured the perspectives of patients; 11.7% featured academic institutions or non-profit organizations; 10.6% featured media outlets; 5.3% featured other health professionals; and 2.1%

Pharmaceutical 69

Pharmaceutical Education Dermatology Clinic 69

The Dermatology Digest

APRIL 11, 2024

The first patient has been treated in Stamford Pharmaceuticals Inc.’s We believe there is an opportunity to further improve patient benefit in locally advanced BCC patients based on the current standard of care,” says Clement Leong, PhD, CEO of Stamford Pharmaceuticals, in a news release.

Pharmaceutical 36

Pharmaceutical Clinic Injections Dermatology 36

Aesthetics Advisor

FEBRUARY 11, 2024

Most medical schools still only teach how to identify late-stage autoimmune disease, not how to identify autoimmunity in its early stages and nor how to affect its progression through dietary, nutritional, pharmaceutical, or lifestyle applications. About the Author: Datis Kharrazian, Ph.D.,

Pharmaceutical 67

Pharmaceutical Diet Clinic Management 67

The Dermatology Digest

MAY 2, 2024

Eblasakimab is a potential first-in-class monoclonal antibody targeting the IL-13 receptor subunit of the Type 2 receptor, a key pathway driving several allergic inflammatory diseases.

Pharmaceutical 74

Pharmaceutical Dermatitis Office Clinic 74

The Dermatology Digest

AUGUST 8, 2024

Both drugs are manufactured by the pharmaceutical company Bristol Myers Squibb, which sponsored the CheckMate-915 trial, and provided the patient specimens and data used in the analysis. All immune cell samples were taken prior to the start of immunotherapy.

Treatments 74

Treatments Pharmaceutical Therapy Dermatology 74

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) and Novartis Pharmaceuticals). Japan is the first country to approve dupilumab for CSU. This study met the primary and all key secondary endpoints.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

Dermatology Times

DECEMBER 18, 2023

Emphasizing the challenges of the steroid treatment cycle, the expert provides insights into integrating parental preferences for "natural" agents alongside effective pharmaceutical options. An expert in skin condition management discusses the case of a 13-year-old male with a prolonged history of AD and early-onset food allergies.

Pharmaceutical 36

Pharmaceutical Management Treatments 36

The Dermatology Digest

JANUARY 5, 2024

Zelsuvmi is expected to be commercially available during the second half of 2024, according to Ligand Pharmaceuticals. Approved in 2023 Verrica Pharmaceuticals’ Ycanth (cantharidin) was the first U.S.-approved Ligand Pharmaceuticals acquired all the assets of Novan, Inc. in September 2023. Novan developed Zelsuvmi.

Pharmaceutical 36

Pharmaceutical Office Medical Dermatology 36

Dermatology Times

OCTOBER 17, 2023

Hilary Baldwin, MD, offers her insights and hypotheses regarding the future of over-the-counter and pharmaceutical treatments, emphasizing the evolving landscape and the potential role of targeted microbiome-based approaches in the management of acne.

Pharmaceutical 36

Pharmaceutical Skincare Management Treatments 36

The Dermatology Digest

JANUARY 5, 2024

The last patient has been dosed in Part 2 of Verrica Pharmaceuticals Inc.’s s Phase 2 trial of VP-315, a potential first-in-class oncolytic peptide, for the treatment of basal cell carcinoma. VP-315 is a chemotherapeutic administered intratumorally.

Pharmaceutical 36

Pharmaceutical Safety Office Clinic 36

Aesthetics Advisor

AUGUST 16, 2023

Novo traded at fresh highs as the Danish pharmaceutical company gained ground on the only European megacap that is larger than it. Makers of syringes for the pharmaceutical industry, Stevanato Group SpA and West Pharmaceutical Services Inc., also gained — rising 9.0% respectively.

Sales 36

Sales Pharmaceutical Marketing Medical 36

Aesthetics Advisor

AUGUST 22, 2023

The pharmaceutical industry doesn’t generate its desired profits by creating common drugs, even though they’re in high demand. In February, Akorn Pharmaceuticals, a company dedicated to producing generic drugs, filed for bankruptcy and had to close all its U.S. What produces higher profits are newer drugs , according to the U.S.

Pharmaceutical 36

Pharmaceutical Hospital Document Medical 36

The Dermatology Digest

JANUARY 4, 2024

Joint development for DMB-3115 was initiated in 2013 by Dong-A Socio Holdings and Meiji Seika Pharma, with exclusive commercialization rights granted to Intas Pharmaceuticals through a partnership announced in 2021. As a global subsidiary of Intas Pharmaceuticals, Accord BioPharma will be responsible for U.S. commercialization.

Pharmaceutical 36

Pharmaceutical Partnerships Clinic Safety 36

The Dermatology Digest

NOVEMBER 30, 2024

LP-310, developed by Lipella Pharmaceuticals for the treatment of oral lichen planus (OLP), is currently in Phase 2 clinical trials. There are currently no drugs specifically approved for lichen planus and available treatments are primarily palliative.

Pharmaceutical 36

Pharmaceutical Safety Marketing Therapy 36

The Dermatology Digest

JULY 5, 2024

Recently, Almirall was rated as one of the top 5% of companies in the pharmaceutical industry by Sustainalytics. Ecovadis recognized Almirall with a platinum medal, placing it in the top 1% of evaluated pharmaceutical companies for sustainability.

Sustainability 36

Sustainability Pharmaceutical Portfolios Management 36

Lipgloss and Aftershave

NOVEMBER 15, 2024

Phyllis Hsieh is the visionary behind Conrex Pharmaceutical Corp. The Permeation Enhancement Technology is FDA-approved in pharmaceuticals. and the creator of SESHA SKIN THERAPY, a professional skincare brand powered by Patented enhancement technology (P.E.T ) technology.

Management 40

Management Microneedling Therapy Pharmaceutical 40

The Eco Well Blog

OCTOBER 17, 2024

E.g. We've been trying for decades to get a viable male birth control pharmaceutical, and still haven’t been successful. These assays are very sensitive to try to find e.g. potential birth control options, which it turns out, is pretty dang hard. Do cosmetics cause endocrine disruption? Realistically, probably not.

Pharmaceutical 52

Pharmaceutical Ingredients 52

The Dermatology Digest

MARCH 11, 2024

Watch Now Sneak Peek Inside the CSU Treatment Pipeline Jason Hawkes, MD, MS Jason Hawkes, MD, MS, a dermatologist in Rocklin, CA, reviews currently available and emerging treatments for chronic spontaneous urticaria (CSU), including dupilumab (Dupixent, Sanofi, and Regeneron Pharmaceuticals), remibrutinib, Novartis’ investigational oral Bruton’s (..)

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69